Mark Cuban, the billionaire entrepreneur best known as the owner of the Dallas Mavericks and a prominent investor on Shark […]
Mark Cuban: Unexpected Leader in Orphan Drug Development Reform Read Post »
Anticipate the Future Global biopharmaceutical markets face constant change. To remain competitive you need to anticipate what’s next. We understand
Helping You Make Better Decisions: The DrugPatentWatch Design Philosophy Read Post »
Artificial Intelligence (AI) is revolutionizing the pharmaceutical industry, transforming the way drugs are discovered, developed, and brought to market. This
How AI Is Already Changing Drug Development Read Post »
By Nanette Moss, S.M., C.I.H., Senior Scientist and Project Executive with Environmental Health & Engineering, Inc. What is business continuity
Business Continuity and Resiliency Planning for Biomedical and Research Organizations Read Post »
In November 2018, the Government Accountability Office (GAO) released a report titled “FDA Could Improve Designation Review Consistency; Rare Disease
Key Findings from GAO Report on Orphan Drug Approval Modernization Read Post »
This article was originally published by Nigel S. Clarke in World Patent Information Volume 54, Supplement, September 2018, Pages S4-S10 under
The basics of patent searching Read Post »
Get fresh news and insights, drug patent expirations & more…
